• 1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P.R.China;
  • 2. Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R.China;
  • 3. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 999077, P.R.China;
  • 4. Chinese Equator Center, Hong Kong 999077, P.R.China;
  • 5. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, P.R.China;
BIAN Zhaoxiang, Email: bianzxiang@gmail.com
Export PDF Favorites Scan Get Citation

高质量的随机对照试验(randomized controlled trials,RCTs)是循证医学的组成部分。随机对照试验是高质量系统评价的基础,是卫生保健政策和临床实践的重要决定因素。为最有效地使用已发表的研究,研究者和作者应遵循准确和透明的 RCTs 报告规范。CONSORT 声明及其扩展版是生物医学研究中使用最广泛的报告规范之一。CONTORT 声明于 2004 年被 American Journal of Orthodontics and Dentofacial Orthopedics 采用。自 2011 年以来,该期刊一直积极遵守 CONSORT 报告规范。本文旨在解释 CONSORT 各条目与这一领域研究报告的相关性及其应用,以帮助作者向本杂志和其他矫正类杂志提交 RCTs 报告时,达到 CONSORT 声明的要求。

Citation: Translated by ZHAO Chen, FU Shufei, DUAN Yuting, ZHANG Chi, SHANG Hongcai, BIAN Zhaoxiang. The CONSORT statement: application within and adaptations for orthodontic trials. Chinese Journal of Evidence-Based Medicine, 2021, 21(2): 219-230. doi: 10.7507/1672-2531.202008177 Copy

  • Previous Article

    Implementing Bayesian meta-analysis of binary data using PROC MCMC process step in the SAS software
  • Next Article

    Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement